INSM
Insmed Incorporated
Company Overview
| Mkt Cap | $35.04B | Price | $184.78 |
| Volume | 1.92M | Change | -2.54% |
| P/E Ratio | -38.3 | Open | $187.90 |
| Revenue | $363.7M | Prev Close | $189.60 |
| Net Income | $-913.8M | 52W Range | $60.40 - $197.08 |
| Div Yield | N/A | Target | $175.39 |
| Overall | 68 | Value | 40 |
| Quality | 65 | Technical | 100 |
No chart data available
Stock Overview
Updated DailyInsmed Incorporated (INSM) is a leading diversified company in the Biotechnology industry, currently trading at $184.78 with a market capitalization of $35.04 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating solid quality metrics with a MarketXLS quality score of 65.
Today's trading session shows INSM with a volume of 1.92 million shares. The stock opened down 0.90% from yesterday's close of $189.60. Current analyst estimates project earnings of $-5.55 per share for this year, with next year targeting $-3.56.
INSM demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including SRPT, VRTX, GILD, ARRY, AERI.
Key investment considerations for INSM include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest limited upside of -5.1%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 4, 2025 at 05:18 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INSM | $184.78 | -2.5% | 1.92M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |